01 1Amphastar France Pharmaceuticals
02 1Amphastar France Pharmaceuticals, Inc.
03 1Biocon Biologics Limited
04 1Biocon Limited
01 1Human Insulin - Bulk (rDNA Origin)
02 1Insulin
03 2Recombinant Human Insulin
01 1India
02 2U.S.A
03 1Blank
NDC Package Code : 69098-101
Start Marketing Date : 2014-07-16
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 69098-101
Start Marketing Date : 2014-07-16
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65727-007
Start Marketing Date : 2005-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 82196-020
Start Marketing Date : 2024-12-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (28.5mg/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
A Insulin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Insulin, including repackagers and relabelers. The FDA regulates Insulin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Insulin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Insulin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Insulin supplier is an individual or a company that provides Insulin active pharmaceutical ingredient (API) or Insulin finished formulations upon request. The Insulin suppliers may include Insulin API manufacturers, exporters, distributors and traders.
click here to find a list of Insulin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Insulin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Insulin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Insulin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Insulin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Insulin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Insulin suppliers with NDC on PharmaCompass.
We have 2 companies offering Insulin
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
